Abstract 362P
Background
Continuity of care is an important domain of provision of Palliative services. Round the clock Consultation liaison services are provided to all registered Patients (through an on-call number manned by the Resident on call). The Investigator's phone number is bieng provided upon Patient request. Advice regarding symptomatic management (including titration of analgesia), counseling regarding goals of care and opportunity to facilitate a liaison with the Patient's Local physician are bieng provided via telephonic consult. Text messages also form a frequent means of providing important treatment related information.
Methods
29 patients who had contacted this Resident during a period extending from November 2017 to May 2019 were invited to take part in an Investigator initiated Telephonic survey.
Results
11 respondents who were also primary caregivers agreed to participate. The remainder either were unreachable or declined to participate. 5/11 respondents had contacted the on call number while 7/11 had contacted the Investigator's number more than twice. 4/7 were satisfied with the response that they received on the on call number. 2 out of 10 respondents had used the number facilitating a liaison between the Resident and Local Physician. There was unanimous agreement on the feasibility and appropriateness of the on call liaison for provision of Bereavement services. There was consensus that the gender of the Resident did not affect Patient preferences. All respondents agreed that the text message had been an important means of disseminating information. Difficult to control pain was identified as the leading indication for seeking a Telephonic liaison. 3/11 respondents opined that the on-call number should be more accessible. 5/7 respondents agreed that they could have been provided better end of life care. Pain, reduced oral intake and constipation were identified as symptoms that caused the maximum amount of concern during the terminal phase of decline. Two caregivers used the opportunity to air grievances about quality of patient care services that they were provided.
Conclusions
Telephonic liaison services have the potential to act as an effective mode of delivery of palliative (including end of life care) services.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Dr. Rahul D. Arora, Senior Resident, Dept. of Palliative Medicine, All India Institute of Medical Scinces, New Delhi, India.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
220P - An outcome analysis of robotassisted radical nephroureterectomy with extended template lymphadenectomy for upper tract urothelial carcinoma
Presenter: Ashwin Tamhankar
Session: Poster display session
Resources:
Abstract
221P - Comparative analysis of first-line immune checkpoint inhibitor versus carboplatin-based chemotherapy for cisplatin-ineligible metastatic urothelial carcinoma: A multicenter, retrospective real-world evidence
Presenter: Hsiang‐Lan Lai
Session: Poster display session
Resources:
Abstract
222P - Does tumor grade really improve the prognostic ability of the staging system for men with penile cancer: A SEER database analysis
Presenter: Ravi Kanodia
Session: Poster display session
Resources:
Abstract
223TiP - EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma
Presenter: Daniel Petrylak
Session: Poster display session
Resources:
Abstract
230P - Olaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort
Presenter: Lingying Wu
Session: Poster display session
Resources:
Abstract
231P - Cost-effectiveness of olaparib vs routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
Presenter: David SP Tan
Session: Poster display session
Resources:
Abstract
233P - Incorporation of correlative studies in ovarian cancers in the era of precision medicine: Assessment of accountability and utility
Presenter: Nadia Hitchen
Session: Poster display session
Resources:
Abstract
234P - Implementation of mainstream BRCA testing in epithelial ovarian cancer in a tertiary centre
Presenter: Edbert Wong
Session: Poster display session
Resources:
Abstract
235P - The efficacy of radiation therapy in ovarian carcinoma: A propensity score analysis of a population-based study
Presenter: Jian-Guo Zhou
Session: Poster display session
Resources:
Abstract
236P - Front-line maintenance therapy for platinum-sensitive ovarian cancer: What’s next PARP inhibitors?
Presenter: Han Gong
Session: Poster display session
Resources:
Abstract